Inventor · disambiguated record
Robert J. Watson
Also filed as: WATSON ROBERT J · WATSON ROBERT JOHN
40 granted patents·10 pending applications·299 citations·filing 1995–2019
97Inventor score
Files withDARWIN DISCOVERY LTD17GLAXOSMITHKLINE IP NO 2 LTD11CELLTECH R&D LTD3GLAXOSMITHKLINE LLC3CHIROSCIENCE LTD2
Top patents by PatentIndex Score
50 records- 0194US6566384B1Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activityDARWIN DISCOVERY LTD·Filed 2001·Granted May 20, 2003·32 cites·19 claims
- 0292US9067936B24-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitorDEMONT EMMANUEL HUBERT·Filed 2012·Granted Jun 30, 2015·18 cites·12 claims
- 0389US9029395B2Tetrahydroquinoline derivatives useful as bromodomain inhibitorsAMANS DOMINIQUE·Filed 2012·Granted May 12, 2015·17 cites·17 claims
- 0485US10370356B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Aug 6, 2019·6 cites·20 claims
- 0585US6465468B1Hydroxamic and carboxylic acid derivativesDARWIN DISCOVERY LTD·Filed 2000·Granted Oct 15, 2002·24 cites·14 claims
- 0679US10583112B2Benzo[b]furans as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Mar 10, 2020·2 cites·22 claims
- 0779US6506773B2Hydroxamic and carboxylic acid derivativesDARWIN DISCOVERY LTD·Filed 2001·Granted Jan 14, 2003·13 cites·12 claims
- 0879US5736549AHypoxanthine and guanine compoundsCHIROSCIENCE LTD·Filed 1995·Granted Apr 7, 1998·49 cites·17 claims
- 0977US5792774AQuinolones and their therapeutic useCHIROSCIENCE LTD·Filed 1997·Granted Aug 11, 1998·22 cites·23 claims
- 1076US10428026B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Oct 1, 2019·2 cites·25 claims
- 1176US6180611B1Peptidyl compoundsDARWIN DISCOVERY LTD·Filed 1999·Granted Jan 30, 2001·37 cites·21 claims
- 1275US9587765B2Sound treatment assembly for a fluid transmission lineEMERSON PROCESS MAN REGULATOR TECHNOLOGIES INC·Filed 2015·Granted Mar 7, 2017·2 cites·14 claims
- 1374US6680338B2Hydroxamic and carboxylic acid derivativesDARWIN DISCOVERY LTD·Filed 2001·Granted Jan 20, 2004·5 cites·10 claims
- 1474US6469020B2Hydroxamic and carboxylic acid derivativesDARWIN DISCOVERY LTD·Filed 2001·Granted Oct 22, 2002·6 cites·15 claims
- 1574US6462042B1Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitorsDARWIN DISCOVERY LTD·Filed 2000·Granted Oct 8, 2002·6 cites·21 claims
- 1673US10966961B2Pyrazole derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Apr 6, 2021·1 cites·17 claims
- 1772US9416130B24-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitorGLAXOSMITHKLINE LLC·Filed 2015·Granted Aug 16, 2016·1 cites·7 claims
- 1870US6118001AHydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activityDARWIN DISCOVERY LTD·Filed 1997·Granted Sep 12, 2000·29 cites·17 claims
- 1966US10927080B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Granted Feb 23, 2021·0 cites·8 claims
- 2066US6734189B2Hydroxamic and carboxylic acid derivativesDARWIN DISCOVERY LTD·Filed 2002·Granted May 11, 2004·2 cites·8 claims
- 2162US6187924B1Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activityDARWIN DISCOVERY LTD·Filed 1998·Granted Feb 13, 2001·9 cites·35 claims
- 2261US9861627B24-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitorGLAXOSMITHKLINE LLC·Filed 2017·Granted Jan 9, 2018·0 cites·6 claims
- 2358US9610284B24-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitorGLAXOSMITHKLINE LLC·Filed 2016·Granted Apr 4, 2017·0 cites·16 claims
- 2454US2004176362A1Hydroxamic and carboxylic acid derivativesFiled 2004·Application pending·0 cites
- 2553US6939829B1Plant and product treatmentFiled 2000·Granted Sep 6, 2005·4 cites·9 claims
- 2650US11273146B2Benzofuran derivatives and their use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Mar 15, 2022·0 cites·21 claims
- 2750US2004127717A1Hydroxamic and carboxylic acid derivativesFiled 2003·Application pending·0 cites
- 2849US7015234B2Hydroxamic acid derivativesCELLTECH R&D LTD·Filed 2002·Granted Mar 21, 2006·0 cites·8 claims
- 2949US6933306B2Hydroxamic and carboxylic acid derivativesDARWIN DISCOVERY LTD·Filed 2002·Granted Aug 23, 2005·0 cites·6 claims
- 3048US2003207889A1Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activityFiled 2003·Application pending·0 cites
- 3148US2003022893A1Hydroxamic and carboxylic acid derivativesFiled 2002·Application pending·0 cites
- 3246US8011703B2Lever handle door furnitureASSA ABLOY AUSTRALIA PTY LTD·Filed 2005·Granted Sep 6, 2011·2 cites·15 claims
- 3346US6455531B1Hydroxamic acid derivativesDARWIN DISCOVERY LTD·Filed 2000·Granted Sep 24, 2002·0 cites·21 claims
- 3446US2006276507A1Hydroxamate sulfonamides as cd23 shedding inhibitorsCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 3545US11319307B22,3-dihydrobenzohurans as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted May 3, 2022·0 cites·18 claims
- 3645US10849897B2Pyridyl derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Dec 1, 2020·0 cites·20 claims
- 3745US2010035863A12 Amino-Pyrimidine Derivatives As H4 Receptor Antagonists, Processes For Preparing Them And Their Use In Pharmaceutical CompositionsUCB PHARMA SA·Filed 2007·Application pending·0 cites
- 3844US5994312APeptidyl compoundsDARWIN DISCOVERY LTD·Filed 1998·Granted Nov 30, 1999·5 cites·24 claims
- 3943US2006241118A1Hydroxamate sulfonamides as cd23 shedding inhibitorsCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 4042US10934272B2Pyridyl derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Mar 2, 2021·0 cites·9 claims
- 4142US2007197589A1Cyclic quaternary amino derivatives as modulators of chemokine receptorsWATSON ROBERT J·Filed 2004·Application pending·0 cites
- 4241US10471050B22-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Nov 12, 2019·0 cites·21 claims
- 4341US8846709B27-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1H-imidazo[4,5-C]quinoline derivativesDEMONT EMMANUEL HUBERT·Filed 2012·Granted Sep 30, 2014·0 cites·13 claims
- 4440US10844015B2Pyridine dicarboxamide derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Nov 24, 2020·0 cites·12 claims
- 4540US6503910B1Hydroxamic and carboxylic acid derivativesDARWIN DISCOVERY LTD·Filed 2000·Granted Jan 7, 2003·0 cites·10 claims
- 4639US6090840APeptidyl compounds having MMP and TNF inhibitory activityDARWIN DISCOVERY LTD·Filed 1997·Granted Jul 18, 2000·3 cites·5 claims
- 4737US2014005188A1Pyrido[3,4-b]pyrazine derivatives as syk inhibitorsATKINSON FRANCIS LOUIS·Filed 2012·Application pending·0 cites
- 4836US6114372APeptidyl compounds having MMP and TNF inhibitory activityDARWIN DISCOVERY LTD·Filed 1997·Granted Sep 5, 2000·2 cites·14 claims
- 4935US2005113414A1Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseasesFiled 2003·Application pending·0 cites
- 5032US6706719B1Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activityDARWIN DISCOVERY LTD·Filed 1999·Granted Mar 16, 2004·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →